Cargando…
Liver transplantation for post-COVID-19 sclerosing cholangitis
Since identified in December 2019, COVID-19 has remained a pandemic across the globe. Although primarily a respiratory illness, the impact of COVID-19 on other end organs has been increasingly identified. The effect of COVID-19 on the liver has yet to be completely understood. We describe a case of...
Autores principales: | Lee, Angela, Wein, Alexander N, Doyle, Maria B Majella, Chapman, William C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395362/ https://www.ncbi.nlm.nih.gov/pubmed/34446515 http://dx.doi.org/10.1136/bcr-2021-244168 |
Ejemplares similares
-
Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006) -
Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation
por: Machado, Marcel Cerqueira Cesar, et al.
Publicado: (2022) -
Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis
por: Sierra, Leandro, et al.
Publicado: (2023) -
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)